# OnCo record nct03213665 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03213665/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03213665", "NCT03213665" ;
  schema:name "Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)"@en ;
  schema:description "A phase 2 trial of Tazemetostat in Sarcomas, run by National Cancer Institute (NCI), completed."@en ;
  schema:url <https://onco.cc/trials/nct03213665/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03213665> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/sarcoma/> ;
  onco:drugs <https://onco.cc/drugs/tazemetostat/> .